| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jul―17 |
Oral Administration of Water-Soluble Curcumin Complex Prevents ARDS With the Potential for COVID-19 Treatment |
Sinan Aktay, Yurixi Lopez-Miranda, Jaakko Parkkinen, Krishnan Raghavendran, Madathilparambil V. Suresh |
| 2 |
[GO] |
2024―Sep―09 |
Phytoconstituents as modulator of inflammatory pathways for COVID-19: A comprehensive review and recommendations |
Pragati Gupta, Kamal Dev, Gurjot Kaur |
| 3 |
[GO] |
2024―Mar―23 |
Curcumin supplementation as a complementary and alternative medicine for COVID-19 patients |
Nader Aghakhani, Hamid Soraya |
| 4 |
[GO] |
2024―Mar―13 |
Effect and mechanism of quercetin or quercetin-containing formulas against COVID-19: From bench to bedside |
Jhong Yuan Chen, Tsung Rung Huang, Shih Yun Hsu, Ching Chun Huang, Huei Syun Wang, Jung San Chang |
| 5 |
[GO] |
2024―Feb―29 |
Long COVID-19 gastrointestinal related disorders and traditional Chinese medicine: A network target-based approach |
Laura Beatrice Mattioli, Maria Frosini, Ivan Corazza, Sirio Fiorino, Maddalena Zippi, Matteo Micucci, Roberta Budriesi |
| 6 |
[GO] |
2024―Jan―29 |
Plant-derived compounds as potential leads for new drug development targeting COVID-19 |
Lingxiu Liu, Maxim Kapralov, Mark Ashton |
| 7 |
[GO] |
2024―Jan―29 |
Flavonoids derived from medicinal plants as a COVID-19 treatment |
Mentor Sopjani, Francesca Falco, Federica Impellitteri, Valeria Guarrasi, Xuan Nguyen Thi, Miribane Dërmaku-Sopjani, Caterina Faggio |
| 8 |
[GO] |
2024―Jan―03 |
Role of dietary supplements in the continuous battle against COVID-19 |
Rahela Zaman, Vignesh Ravichandran, Chung Keat Tan |
| 9 |
[GO] |
2023―Nov―24 |
The influence of propolis plus Hyoscyamus niger L. against COVID-19: A phase II, multicenter, placebo-controlled, randomized trial |
Morteza Kosari, Farzin Khorvash, Mohammad Kazem Sayyah, Maryam Ansari Chaharsoughi, Ahmad Najafi, Mansooreh Momen-Heravi, Mohammad Karimian, Hossein Akbari, Mehdi Noureddini, Mahmoud Salami, Amir Ghaderi, Javad Amini Mahabadi, Seyed Peyman Khamechi, Somayeh Yeganeh, Hamid Reza Banafshe |
| 10 |
[GO] |
2023―Sep―20 |
Cinnamaldehyde inhibits cytokine storms induced by the ORF3a protein of SARS-CoV-2 via ROS-elimination in activated T cells |
Jing Ma, Xu Chen, Rui Xue, Fei Wang, Jun Dong, Ning Tao, Zhihai Qin |
| 11 |
[GO] |
2023―Aug―19 |
Achyrocline satureioides as an adjuvant therapy for the management of mild viral respiratory infections in the context of COVID-19: Preliminary results of a randomized, placebo-controlled, and open-label clinical trial |
Catherina Isdra Moszkowicz Bastos, Caroline Dani, Laura Reck Cechinel, Arthur Hipolito da Silva Neves, Fabiana Briato Rasia, Sara Elis Bianchi, Eloisa da Silveira Loss, Marcelo Lazzaron Lamers, Gabriela Meirelles, Valquiria Linck Bassani, Ionara Rodrigues Siqueira |
| 12 |
[GO] |
2023―Jun―08 |
Therapeutic prospects of naturally occurring p38 MAPK inhibitors tanshinone IIA and pinocembrin for the treatment of SARS-CoV-2-induced CNS complications |
Mehdi Valipour |
| 13 |
[GO] |
2023―May―11 |
Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (
SARS-CoV
-2) binding to angiotensin-converting enzyme 2 |
Junjie Zhu, Huimin Yan, Mengyao Shi, Min Zhang, Jia Lu, Jiabao Wang, Lu Chen, Yu Wang, Lin Li, Lin Miao, Han Zhang |
| 14 |
[GO] |
2023―Apr―12 |
Validation of baicalein and oridonin as nonspecific
SARS-CoV
-2 main protease inhibitors |
Haohao Yan, Rui Zhang, Gangan Yan, Xiaoping Liu, Ni Li, Yunyu Chen |
| 15 |
[GO] |
2023―Feb―14 |
Multi-target approach against
SARS-CoV
-2 by stone apple molecules: A master key to drug design |
Rahul Singh, Rituraj Purohit |
| 16 |
[GO] |
2023―Jan―27 |
Kaempferol's potential effects against
SARS-CoV
-2 and
COVID
-19-associated cancer progression and chemo-resistance |
Hamidreza Zalpoor, Mahsa Liaghat, Maryam Bakhtiyari, Hooriyeh Shapourian, Abdullatif Akbari, Shaghayegh Shahveh, Mohsen Nabi-Afjadi, Sohrab Minaei Beirami, Vahideh Tarhriz |
| 17 |
[GO] |
2022―Nov―24 |
Phase
III
randomized clinical trial of
BV
-4051, an Ayurvedic polyherbal formulation in moderate
SARS-CoV
-2 infections and its impact on inflammatory biomarkers |
Deepa Chitre, Satej Nadkarni, Namdev Jagtap, Rahul Tulle, Amol Gitte, Prashant Rahate, Sunetra Chaskar, Debendranath Dey |
| 18 |
[GO] |
2022―Nov―22 |
Antcin A, a phytosterol regulates
SARS-CoV
-2 spike protein-mediated metabolic alteration in
THP
-1 cells explored by the
1
H-NMR
-based metabolomics approach |
Gyaltsen Dakpa, Kanthasamy Jayabal Senthil Kumar, Nai-Wen Tsao, Sheng-Yang Wang |
| 19 |
[GO] |
2022―Nov―16 |
Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (
COVID
-19): A systematic review and meta-analysis of randomized controlled trials |
Di Jin, Jing Wang, Jiaojiao Xue, Yunyun Zhao, Guanchi Yan, Xiangyan Li, Xiuge Wang |
| 20 |
[GO] |
2022―Nov―07 |
Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review |
Ibrahim Jantan, Laiba Arshad, Abdi Wira Septama, Md. Areeful Haque, Zeti-Azura Mohamed-Hussein, Nisha T. Govender |
| 21 |
[GO] |
2022―Aug―09 |
Broad-spectrum antiviral activity of
Spatholobus suberectus
Dunn against
SARS-CoV
-2,
SARS-CoV
-1,
H5N1
, and other enveloped viruses |
Qingqing Liu, Ka-Yi Kwan, Tianyu Cao, Bingpeng Yan, Kumar Ganesan, Lei Jia, Feng Zhang, Chunyu Lim, Yaobin Wu, Yibin Feng, Zhiwei Chen, Li Liu, Jianping Chen |
| 22 |
[GO] |
2022―Aug―08 |
Phytoncides could potentially inhibit the spike protein of
SARS-CoV
-2 variants |
Muruganantham Bharathi, Bhagavathi Sundaram Sivamaruthi, Periyanaina Kesika, Subramanian Thangaleela, Chaiyavat Chaiyasut |
| 23 |
[GO] |
2022―Aug―06 |
Promising natural products against
SARS-CoV
-2: Structure, function, and clinical trials |
Yan Zhao, Shanshan Deng, Yujiao Bai, Jinlin Guo, Guoyin Kai, Xinhe Huang, Xu Jia |
| 24 |
[GO] |
2022―Aug―02 |
High-quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID-19 |
Nan Huang, Saichao Li |
| 25 |
[GO] |
2022―Jul―21 |
Evaluation of the efficacy of oral nano-silymarin formulation in hospitalized patients with COVID-19: A double-blind placebo-controlled clinical trial |
Hossein Aryan, Ramin Hamidi Farahani, Mohsen Chamanara, Sepideh Elyasi, Mahmoud Reza Jaafari, Mahboubeh Haddad, Ashraf Tavanaee Sani, Mohamed Afshar Ardalan, Reza Mosaed |
| 26 |
[GO] |
2022―May―21 |
Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2 |
Rania Hamdy, Ahmed Mostafa, Noura M. Abo Shama, Sameh S. M. Soliman, Bahgat Fayed |
| 27 |
[GO] |
2022―Apr―09 |
In vitro antiviral activity against
SARS-CoV
-2 of common herbal medicinal extracts and their bioactive compounds |
Kristi Leka, Carla Hamann, Pauline Desdemoustier, Michel Frédérich, Mutien-Marie Garigliany, Allison Ledoux |
| 28 |
[GO] |
2022―Mar―31 |
Therapeutic potential of loureirin A against
SARS-CoV
-2 infection |
Mohammad Rafi Khezri, Donya Moloodsouri, Darya Hodaei, Morteza Ghasemnejad-Berenji |
| 29 |
[GO] |
2022―Mar―21 |
Quercetin potential effects against
SARS-CoV
-2 infection and
COVID
-19-associated cancer progression by inhibiting
mTOR
and hypoxia-inducible factor-1α (
HIF
-1α) |
Hamidreza Zalpoor, Maryam Bakhtiyari, Mahsa Liaghat, Mohsen Nabi-Afjadi, Mazdak Ganjalikhani-Hakemi |
| 30 |
[GO] |
2022―Mar―01 |
Antiviral activity of plant juices and green tea against
SARS-CoV
-2 and influenza virus |
Maren Eggers, Peggy Jungke, Volker Wolkinger, Rudolf Bauer, Uwe Kessler, Bruno Frank |
| 31 |
[GO] |
2022―Jan―26 |
In vitro antiviral activity against
SARS-CoV
-2 of 28
Strychnos
extracts |
Allison Ledoux, Kristi Leka, Olivier Bonnet, Aude Blanquer, Tiabou Tchinda Alembert, Patrick Silva Mirowski, Patricia Oliveira Figueiredo, Daniel Desmecht, Mutien-Marie Garigliany, Michel Frédérich |
| 32 |
[GO] |
2022―Jan―18 |
Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial |
Ali Asadirad, Roohangiz Nashibi, Ali Khodadadi, Ata A Ghadiri, Mahvash Sadeghi, Azam Aminian, Sajad Dehnavi |
| 33 |
[GO] |
2022―Jan―13 |
Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomized double-blind placebo-controlled trial |
Elaheh Honarkar Shafie, Fateme Taheri, Neda Alijani, Ahmad Reza Okhovvat, Razieh Goudarzi, Nasrin Borumandnia, Leila Aghaghazvini, Seyed Mahdi Rezayat, Saeidreza Jamalimoghadamsiahkali, Mohammad Javad Hosseinzadeh-Attar |
| 34 |
[GO] |
2021―Dec―11 |
Plant cysteine proteases: Potential therapeutic agents against
SARS-CoV
-2 |
Filippe Elias de Freitas Soares, Mariana Aparecida de Freitas Abreu |
| 35 |
[GO] |
2021―Oct―26 |
Garcinia kola
and garcinoic acid suppress
SARS-CoV
-2 spike glycoprotein
S1
-induced hyper-inflammation in human
PBMCs
through inhibition of
NF-κB
activation |
Olumayokun A Olajide, Victoria U Iwuanyanwu, Izabela Lepiarz-Raba, Alaa A Al-Hindawi, Mutalib A Aderogba, Hazel L Sharp, Robert J Nash |
| 36 |
[GO] |
2021―Oct―16 |
Cannabidiol inhibits
SARS-Cov
-2 spike (S) protein-induced cytotoxicity and inflammation through a
PPARγ
-dependent
TLR4
/
NLRP3
/Caspase-1 signaling suppression in Caco-2 cell line |
Chiara Corpetti, Alessandro Del Re, Luisa Seguella, Irene Palenca, Sara Rurgo, Barbara De Conno, Marcella Pesce, Giovanni Sarnelli, Giuseppe Esposito |
| 37 |
[GO] |
2021―Sep―02 |
Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome
-CoV
-2 viruses through blocking virus invasion and antiinflammatory effect |
Shaopeng Yu, Yao Chen, Yusen Xiang, He Lin, Mengge Wang, Wenbo Ye, Pei Zhang, Hongzhuan Chen, Guoqiang Lin, Yuying Zhu, Lili Chen, Jiange Zhang |
| 38 |
[GO] |
2021―Jul―13 |
Contribution of traditional Chinese medicine combined with conventional western medicine treatment for the novel coronavirus disease (
COVID
-19), current evidence with systematic review and meta-analysis |
Fei Jiang, Nana Xu, Yanxi Zhou, Jinxing Song, Jinjuan Liu, Hong Zhu, Jihong Jiang, Yonghong Xu, Rongpeng Li |
| 39 |
[GO] |
2021―Jun―16 |
Promising traditional Indian medicinal plants for the management of novel Coronavirus disease: A systematic review |
Rahul Soloman Singh, Ashutosh Singh, Harpinder Kaur, Gitika Batra, Phulen Sarma, Hardeep Kaur, Anusuya Bhattacharyya, Amit Raj Sharma, Subodh Kumar, Sujata Upadhyay, Vinod Tiwari, Pramod Avti, Ajay Prakash, Bikash Medhi |
| 40 |
[GO] |
2021―Jun―11 |
Therapeutic targets of natural products for the management of cardiovascular symptoms of coronavirus disease 2019 |
Pardis Mohammadi Pour, Mohammad Hosein Farzaei, Ebrahim Soleiman Dehkordi, Anupam Bishayee, Sedigheh Asgary |
| 41 |
[GO] |
2021―Apr―16 |
The effect of propolis plus
Hyoscyamus niger
L. methanolic extract on clinical symptoms in patients with acute respiratory syndrome suspected to
COVID
-19: A clinical trial |
Morteza Kosari, Mehdi Noureddini, Seyed Peyman Khamechi, Ahmad Najafi, Amir Ghaderi, Mojtaba Sehat, Hamid Reza Banafshe |
| 42 |
[GO] |
2021―Apr―06 |
Silibinin as potential tool against
SARS-Cov
-2: In silico spike
receptor-binding
domain and main protease molecular docking analysis, and in vitro endothelial protective effects |
Antonio Speciale, Claudia Muscarà, Maria Sofia Molonia, Francesco Cimino, Antonella Saija, Salvatore Vincenzo Giofrè |
| 43 |
[GO] |
2021―Apr―02 |
In silico approach of secondary metabolites from Brazilian herbal medicines to search for potential drugs against
SARS-CoV
-2 |
Tatiane R. Amparo, Janaína B. Seibert, Tamires C. Almeida, Fernanda S. F. Costa, Benila M. Silveira, Glenda N. Silva, Orlando D. H. Santos, Gustavo H. B. Souza |
| 44 |
[GO] |
2021―Mar―31 |
Flavonoids as potential phytotherapeutics to combat cytokine storm in
SARS-CoV
-2 |
Abhishek Gour, Diksha Manhas, Swarnendu Bag, Bapi Gorain, Utpal Nandi |
| 45 |
[GO] |
2021―Mar―24 |
Plant-derived chemicals as potential inhibitors of
SARS-CoV
-2 main protease (
6LU7
), a virtual screening study |
Mohsen Sisakht, Amir Mahmoodzadeh, Maryam Darabian |
| 46 |
[GO] |
2021―Feb―18 |
Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme
II
/cell membrane chromatography |
Jiapan Gao, Yuanyuan Ding, Yuejin Wang, Peida Liang, Liyang Zhang, Rui Liu |
| 47 |
[GO] |
2021―Jan―15 |
In silico
and
in vitro
evaluation of kaempferol as a potential inhibitor of the
SARS-CoV
-2 main protease (
3CLpro
) |
Abbas Khan, Wang Heng, Yanjing Wang, Jingfei Qiu, Xiaoyong Wei, Shaoliang Peng, Shoaib Saleem, Mazhar Khan, Syed Shujait Ali, Dong-Qing Wei |
| 48 |
[GO] |
2021―Jan―03 |
Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized
coronavirus disease
-19 patients: An open label nonrandomized clinical trial |
Niloofar Saber-Moghaddam, Soofia Salari, Sepideh Hejazi, Mahnaz Amini, Zhila Taherzadeh, Saeed Eslami, Seyed Mahdi Rezayat, Mahmoud Reza Jaafari, Sepideh Elyasi |
| 49 |
[GO] |
2020―Dec―31 |
Phytotherapeutic options for the treatment of COVID-19: A concise viewpoint |
|
| 50 |
[GO] |
2020―Dec―22 |
Traditional herbal medicines to overcome stress, anxiety and improve mental health in outbreaks of human coronaviruses |
Mohamad H. Shahrajabian, Wenli Sun, Ali Soleymani, Qi Cheng |
| 51 |
[GO] |
2020―Nov―22 |
Resveratrol inhibits the replication of severe acute respiratory syndrome coronavirus 2 (
SARS-CoV
-2) in cultured Vero cells |
Minghui Yang, Jinli Wei, Ting Huang, Luping Lei, Chenguang Shen, Jinzhi Lai, Min Yang, Lei Liu, Yang Yang, Guoshi Liu, Yingxia Liu |
| 52 |
[GO] |
2020―Oct―09 |
A role for quercetin in coronavirus disease 2019 (COVID-19) |
Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, Francesco Di Pierro |
| 53 |
[GO] |
2020―Sep―28 |
Natural products for
COVID
-19 prevention and treatment regarding to previous coronavirus infections and novel studies |
Motahareh Boozari, Hossein Hosseinzadeh |
| 54 |
[GO] |
2020―Sep―24 |
The natural way forward: Molecular dynamics simulation analysis of phytochemicals from Indian medicinal plants as potential inhibitors of
SARS-CoV
-2 targets |
Pratap Kumar Parida, Dipak Paul, Debamitra Chakravorty |
| 55 |
[GO] |
2020―Sep―23 |
Aframomum melegueta
secondary metabolites exhibit polypharmacology against
SARS-CoV
-2 drug targets: in vitro validation of furin inhibition |
I. Olaposi Omotuyi, Oyekanmi Nash, Basiru O. Ajiboye, Victor O. Olumekun, Babatunji E. Oyinloye, Oludare T. Osuntokun, Adebisi Olonisakin, A. Olajide Ajayi, Olasehinde Olusanya, Funmilola S. Akomolafe, Niyi Adelakun |
| 56 |
[GO] |
2020―Sep―18 |
Bee products as a source of promising therapeutic and chemoprophylaxis strategies against
COVID
-19 (
SARS-CoV
-2) |
William G. Lima, Júlio C. M. Brito, Waleska S. Cruz Nizer |
| 57 |
[GO] |
2020―Sep―15 |
Glycyrrhizin: An old weapon against a novel coronavirus |
Julian Chrzanowski, Alicja Chrzanowska, Wojciech Graboń |
| 58 |
[GO] |
2020―Aug―12 |
Traditional and complementary medicine during
COVID
-19 pandemic |
Shuvadeep Ganguly, Sameer Bakhshi |
| 59 |
[GO] |
2020―Aug―11 |
High affinity interaction of
Solanum tuberosum
and
Brassica juncea
residue smoke water compounds with proteins involved in coronavirus infection |
Gaurav S. Dave, Kalpna D. Rakholiya, Mital J. Kaneria, Bhemji P. Galvadiya, Sudhanshu R. Vyas, Vaktabhai H. Kanbi, Manubhai P. Patel |
| 60 |
[GO] |
2020―Aug―04 |
Evaluation of medicinal herbs as a potential therapeutic option against
SARS-CoV
-2 targeting its main protease |
Saurabh Upadhyay, Praveen K. Tripathi, Manju Singh, Siva Raghavendhar, Mohit Bhardwaj, Ashok K. Patel |
| 61 |
[GO] |
2020―Jul―02 |
Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19 |
Helda Tutunchi, Fatemeh Naeini, Alireza Ostadrahimi, Mohammad Javad Hosseinzadeh-Attar |
| 62 |
[GO] |
2020―Jun―26 |
Covid-19 and Thymoquinone: Connecting the Dots |
Ajaz Ahmad, Muneeb U Rehman, Parvaiz Ahmad, Khalid M. Alkharfy |
| 63 |
[GO] |
2020―May―29 |
Food as medicine: a possible preventive measure against coronavirus disease (
COVID
-19) |
Yang Fan, Yue Zhang, Akash Tariq, Xiaolan Jiang, Zeeshan Ahamd, Zhang Zhihao, Muhammad Idrees, Azizullah Azizullah, Muhammad Adnan, Rainer W. Bussmann |
| 64 |
[GO] |
2020―Apr―30 |
Phytotherapic compounds against coronaviruses: possible streams for future research |
Michele Antonelli, Davide Donelli, Valentina Maggini, Fabio Firenzuoli |
| 65 |
[GO] |
2020―Apr―05 |
Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data |
Muhammad Torequl Islam, Chandan Sarkar, Dina M. El-Kersh, Sarmin Jamaddar, Shaikh Jamal Uddin, Jamil A. Shilpi, Mohammad S. Mubarak |
